P, O., L, T., P, S., K, T., C, E., MP, G., & K, C. (2019). In silico identification and in vitro validation of nogalamycin N-oxide (NSC116555) as a potent anticancer compound against non-small-cell lung cancer cells. Journal of cellular biochemistry, 120(3), 3353. https://doi.org/10.1002/jcb.27605
Chicago Style (17th ed.) CitationP, Obounchoey, Tabtimmai L, Suphakun P, Thongkhao K, Eurtivong C, Gleeson MP, and Choowongkomon K. "In Silico Identification and in Vitro Validation of Nogalamycin N-oxide (NSC116555) as a Potent Anticancer Compound Against Non-small-cell Lung Cancer Cells." Journal of Cellular Biochemistry 120, no. 3 (2019): 3353. https://doi.org/10.1002/jcb.27605.
MLA (9th ed.) CitationP, Obounchoey, et al. "In Silico Identification and in Vitro Validation of Nogalamycin N-oxide (NSC116555) as a Potent Anticancer Compound Against Non-small-cell Lung Cancer Cells." Journal of Cellular Biochemistry, vol. 120, no. 3, 2019, p. 3353, https://doi.org/10.1002/jcb.27605.